Key statistics
On Tuesday, argenx SE (ARGX:BRU) closed at 644.40, -20.44% below its 52-week high of 810.00, set on Nov 20, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 643.00 |
|---|---|
| High | 655.60 |
| Low | 640.40 |
| Bid | 641.00 |
| Offer | 655.00 |
| Previous close | 649.40 |
| Average volume | 101.15k |
|---|---|
| Shares outstanding | 61.88m |
| Free float | 61.88m |
| P/E (TTM) | 39.73 |
| Market cap | 40.63bn EUR |
| EPS (TTM) | 16.52 EUR |
Data delayed at least 15 minutes, as of Mar 03 2026 16:39 GMT.
More ▼
- argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
- argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
- argenx to Present at TD Cowen 46th Annual Healthcare Conference
- argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
- argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
- argenx Highlights 2026 Strategic Priorities
- argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
- argenx Announces Leadership Transition Marking Next Evolution of Growth
- argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
- argenx Announces Results of Extraordinary General Meeting of Shareholders
More ▼
